Skip to Content

Research

Robert J. Dole VA Medical Center conducts research to discover knowledge, develop VA scientists and health care leaders, and create innovations that advance health care for Veterans and the nation.

Our Research Program

In early 2021, the Robert J. Dole VA Medical Center began a journey to establish a research service. Later that year, the RJDVAMC was approved to participate in the All of Us research study, sponsored by the National Institute of Health and the Million Veteran Program sponsored by the VA. 

In late 2022, the Robert J. Dole VA was named a CSP ACCESS site. As such, the medical center was assigned Louis Stokes VA in Cleveland, a CSP Node site, as a mentor.  This relationship has already resulted in the Dole VA being considered for multiple current CSP studies and multiple industry-funded trials are now being carefully planned.

Since initiating a research service, the department has grown quickly and has reached several milestones in this short period of time.  Due to the dedication and hard work of our investigators, coordinators and support staff, the facility has been approved for and actively participating in a wide range of locally developed and industry sponsored studies to include, oncology, pharmacology, psychology, AI, cardiology, pulmonary, education, and has established a research data repository as a resource for future psychology studies. 

Our active studies include the below specialties and we have completed multiple studies pending final results / findings.

  • Oncology (cancers) - two active studies
  • Affiliate education study with Wichita State University
  • Pharmacology - two active studies
  • Artificial Intelligence
  • Neuropsychology (five publications from RJDVAMC researchers)
  • Cardiology
  • Dementia
  • Genetics
  • Multiple retrospective studies (utilizing historical data) to improve Veteran care
  • QUERI (Implementing research study findings into Veteran care).

Since our activation in 2021, we have opened and or closed 23 research studies.

Approved NCI IRB cancer studies being conducted at RJDVAMC, and several more in the works: 

  • Forte - Study to determine best timing for a repeat colonoscopy for patients with 1 or 2 small benign polyps removed during colonoscopy.
  • Pragmatica - New treatment methods for Veterans previously treated with immunotherapy for stage IV or recurrent non-small cell lung cancer (closed).
  • A212102 - Developing blood test to ID certain cancers.

Last updated: